Invivyd
IVVD
59 hedge funds and large institutions have $220M invested in Invivyd in 2023 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 17 increasing their positions, 17 reducing their positions, and 10 closing their positions.
248% more call options, than puts
Call options by funds: $623K | Put options by funds: $179K
142% more capital invested
Capital invested by funds: $90.9M → $220M (+$129M)
10% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 10
1.94% more ownership
Funds ownership: 48.72% → 50.67% (+1.9%)
2% more funds holding
Funds holding: 58 → 59 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 17
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MC
Maverick Capital
Dallas,
Texas
|
+$7.7M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$862K |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$664K |
| 4 |
Jane Street
New York
|
+$307K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$197K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
-$2.16M |
| 2 |
Millennium Management
New York
|
-$1.21M |
| 3 |
6CM
683 Capital Management
New York
|
-$757K |
| 4 |
TCM
Tang Capital Management
San Diego,
California
|
-$623K |
| 5 |
Citigroup
New York
|
-$453K |
IVVD Hedge Fund Activity: Q4 2023 in Review
59 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Invivyd (IVVD) for Q4 2023, worth a combined $220M — up 142% from $90.9M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new IVVD positions and 10 closed out — a net gain of 1 holder — while 17 added to existing stakes and 17 trimmed.
The largest buyer was Maverick Capital, adding an estimated $7.7M. The largest seller was OrbiMed, cutting an estimated $2.16M.
- 59 institutional investors held Invivyd (IVVD) as of Q4 2023, up from 58 in Q3 2023.
- Funds reported $220M of Invivyd stock for Q4 2023, up 142% quarter-over-quarter.
- 11 funds opened new Invivyd positions in Q4 2023 and 10 closed out, a net change of +1 holder.
- The largest Invivyd buyer in Q4 2023 was Maverick Capital, an estimated $7.7M added.
- The largest Invivyd seller in Q4 2023 was OrbiMed, an estimated $2.16M sold.
Based on aggregated 13F filings for Q4 2023.